BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36544113)

  • 1. Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia.
    Liang T; Peng Z; Li C; Huang J; Wang H; Bu C; Li J; Zheng Y; Feng X; Li H; Chen C
    BMC Cancer; 2022 Dec; 22(1):1339. PubMed ID: 36544113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of CD56 Antigen Expression in Patients with
    Sun Y; Wan J; Song Q; Luo C; Li X; Luo Y; Huang X; Ding R; Li H; Hou Y; Huang Y; Xie M; Huang Z; Zhang Y; Ma Y; Wu G; Xu S; Chen J
    Biomed Res Int; 2021; 2021():1929357. PubMed ID: 33928145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of CD56 Expression on Prognosis of AML Patients with AML/ETO Mutation].
    Zhao J; Zhang HT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):63-67. PubMed ID: 32027254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
    Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study.
    Klein K; Beverloo HB; Zimmermann M; Raimondi SC; von Neuhoff C; de Haas V; van Weelderen R; Cloos J; Abrahamsson J; Bertrand Y; Dworzak M; Fynn A; Gibson B; Ha SY; Harrison CJ; Hasle H; Elitzur S; Leverger G; Maschan A; Razzouk B; Reinhardt D; Rizzari C; Smisek P; Creutzig U; Kaspers GJL
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29341. PubMed ID: 34532968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.
    Djunic I; Virijevic M; Djurasinovic V; Novkovic A; Colovic N; Kraguljac-Kurtovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
    Med Oncol; 2012 Sep; 29(3):2077-82. PubMed ID: 22081445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
    Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
    Aref S; Abousamra N; El-Helaly E; Mabed M
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
    Pardo LM; Voigt AP; Alonzo TA; Wilson ER; Gerbing RB; Paine DJ; Dai F; Menssen AJ; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Wells DA; Brodersen LE; Loken MR
    Cytometry B Clin Cytom; 2020 Jan; 98(1):52-56. PubMed ID: 31294507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and survival analysis of patients with CD56 expression in de- novo acute myeloid leukemia with t(8;21)].
    Liu S; Wei X; Mi R; Ai H; Yin Q; Wang P; Wang X; Fan R; Hu J; Zhu X; Zhou J; Fu Y; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2015 Aug; 36(8):676-81. PubMed ID: 26462638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Features and Prognosis of 227 cases of Acute Myeloid Leukemia with Cross-lineage Antigen Expression].
    Fang F; Zhu P; Zhang Y; Lu XZ; Dong YJ; Sun YH; Wang LH; Bu DF; Cen XN; Wang MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):990-7. PubMed ID: 27531762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
    Chen C; Chio CL; Zeng H; Li Y
    Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
    Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.
    Raspadori D; Damiani D; Lenoci M; Rondelli D; Testoni N; Nardi G; Sestigiani C; Mariotti C; Birtolo S; Tozzi M; Lauria F
    Leukemia; 2001 Aug; 15(8):1161-4. PubMed ID: 11480556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis.
    Juncà J; Garcia-Caro M; Granada I; Rodríguez-Hernández I; Torrent A; Morgades M; Ribera JM; Millá F; Feliu E
    Ann Hematol; 2014 Sep; 93(9):1483-9. PubMed ID: 24782118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
    Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
    Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
    Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
    Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.